Monday, November 23, 2009

Schizophrenia Home>
News>
Schizophrenia drug meets trial goals

Font size
- A
- A
- A
Email This

Bookmark

Save

Schizophrenia drug meets trial goals

(Reuters) UPDATED 2009-08-27

The experimental schizophrenia drug lurasidone improved symptoms significantly better than a placebo in a late-stage clinical trial. A six-week study of 478 patients found that the drug helped users improve their scores in the Positive and Negative Syndrome Scale, as well as the Clinical Global Impressions Severity scale, the drugmaker said. Weight gain was also less on lurasidone than in other antipsychotic drugs. Drugmaker Dainippon says it will likely seek FDA approval for the medication in early 2010. Read full story >

See all Schizophrenia News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on SchizophreniaConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.